Survival analysis indicated that glioma patients exhibiting high BCAT1 expression and low CHIP expression had shorter overall survival compared to those with low BCAT1 expression and high CHIP expression (Fig. 8G, H). Here, STUB1 is linked to central nervous system cancer.